The Food and Drug Administration (FDA) has recently announced that they were issuing emergency use approval for the Johnson & Johnson vaccine. In stage 3 clinical trials, one dose of the vaccine was 85% protective against the most severe cases of COVID-19. This is now the third COVID-19 vaccine available in the United States. Shipments to states will begin over…
![COVID-19 vaccine trials: Live updates](https://sanaclinic.com/demo/wp-content/uploads/2024/02/200520213446769107blog-one-760x485.jpg)